Market Place
Sourcing Support
All News #Library
Takeda’s Deqsiga Receives Approval In Europe
02 May 2025 //
EMA
Takeda`s Deqsiga Receives Approval in Europe
02 May 2025 //
EMA
Takeda Pharmaceutical`s Fruzaqla (fruquintinib) Receives Approval in Europe
20 Jun 2024 //
EMA
Takeda Pharms USA`s Entyvio (vedolizumab) Receives Suppl Approval In the US
19 Apr 2024 //
FDA
Takeda Pharma`s Biologic Entyvio (vedolizumab) Receives Approval in the U.S.
23 Feb 2024 //
FDA
Takeda Pharmaceuticals` Livtencity (maribavir) Approved In Europe
05 Jul 2023 //
EMA
Takeda Pharmaceuticals` Livtencity (Maribavir) Receives Approval in Europe
17 Mar 2023 //
EMA
Takeda`s Qdenga Receives Approval in Europe
30 Jan 2023 //
EMA
Takeda`s Biologic Entyvio (Vedolizumab) Receives Approval in the U.S.
25 Jan 2023 //
FDA
Takeda Qdenga Approved In Europe
16 Dec 2022 //
EMA
Takeda `s Instanyl Receives Approval in Europe
08 Dec 2022 //
EMA
Eli Lilly`s Livtencity (maribavir) Receives Approval in the Europe
24 Nov 2022 //
EMA
Takeda Pharms Usa`s Biological Vedolizumab Receives Approval In the US
17 Aug 2021 //
FDA
Takeda Pharm USA Entyvio (Vedolizumab) Receives Supplemental Approval In US
09 May 2019 //
FDA
Takeda Pharma`s Alunbrig (brigatinib) Receives Approval in Europe
27 Nov 2018 //
EMA
Takeda`s Ninlaro (ixazomib citrate) Receives Conditional approval in Europe
20 Oct 2018 //
EMA
Takeda`s Entyvio (Vedolizumab) Receives Supplemental Approval In US
22 Feb 2018 //
FDA
Takeda Gets EU Nod For Ninlaro (ixazomib citrate)
07 Dec 2016 //
EMA
Novartis snags EU approval for multiple myeloma med Farydak
04 Sep 2015 //
FIERCE PHARMA
Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)
02 Sep 2015 //
PR NEWS WIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.